HomeCompareSPHD vs ZBH

SPHD vs ZBH: Dividend Comparison 2026

SPHD yields 4.33% · ZBH yields 1.08%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPHD wins by $5.3K in total portfolio value
10 years
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →

Portfolio growth — SPHD vs ZBH

📍 SPHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPHDZBH
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPHD + ZBH cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPHD pays
ZBH pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
At 15% tax rate, SPHD beats the other by $384.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPHD + ZBH for your $10,000?

SPHD: 50%ZBH: 50%
100% ZBH50/50100% SPHD
Portfolio after 10yr
$23.9K
Annual income
$344.98/yr
Blended yield
1.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ZBH right now

SPHD
No analyst data
ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPHD buys
0
ZBH buys
0
No recent congressional trades found for SPHD or ZBH in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPHDZBH
Forward yield4.33%1.08%
Annual dividend / share$2.14$0.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.2%
Portfolio after 10y$26.5K$21.2K
Annual income after 10y$571.32$118.64
Total dividends collected$5.1K$1.1K
Payment frequencyquarterlyquarterly
SectorETFHealthcare

Year-by-year: SPHD vs ZBH ($10,000, DRIP)

YearSPHD PortfolioSPHD Income/yrZBH PortfolioZBH Income/yrGap
1← crossover$11,133$432.85$10,809$108.54+$324.00SPHD
2$12,363$450.36$11,675$109.86+$688.00SPHD
3$13,695$467.39$12,603$111.13+$1.1KSPHD
4$15,138$483.90$13,598$112.34+$1.5KSPHD
5$16,697$499.88$14,663$113.51+$2.0KSPHD
6$18,382$515.31$15,804$114.62+$2.6KSPHD
7$20,198$530.17$17,026$115.69+$3.2KSPHD
8$22,157$544.46$18,335$116.71+$3.8KSPHD
9$24,266$558.18$19,736$117.70+$4.5KSPHD
10$26,536$571.32$21,236$118.64+$5.3KSPHD

SPHD vs ZBH: Complete Analysis 2026

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →
📬

Get this SPHD vs ZBH comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPHD vs SCHDSPHD vs JEPISPHD vs OSPHD vs KOSPHD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.